Respiratory mechanics before and after late artificial surfactant rescue

J Paediatr Child Health. 1995 Dec;31(6):532-6. doi: 10.1111/j.1440-1754.1995.tb00878.x.

Abstract

Objective: To assess the effect of late administration of synthetic surfactant (Exosurf) on the ventilatory function of premature infants with hyaline membrane disease (HMD).

Methodology: Prospective non-randomized study in the Neonatal Intensive Care Unit (NICU) of a major referral hospital. The patients included two groups of premature infants with a birthweight between 750 and 2000 g who developed HMD. In group 1 with moderate to severe HMD, 2 x 5 mL/kg doses of Exosurf were given 12 h apart (first dose given at a mean age of 18.7 +/- 3.4 h [mean +/- s.e.m.]). In group 2 with milder HMD, no surfactant was given.

Results: Significant reductions (P < 0.05) in the fraction of inspired oxygen (FIO2) occurred 6 h after surfactant administration (24 h of life) and by 48 h (64 h of life) in group 2. These improvements in gas exchange preceded improvements in passive respiratory compliance which occurred 24 h after surfactant (42 h of life) and by 72 h (88 h of life) in group 2 (P < 0.01). In both groups pulmonary resistance increased and was significant (P < 0.05) by 48 h (66 h of life) in group 1.

Conclusions: Synthetic surfactant given as late as a mean age 18.7 +/- 3.4 h still improves gas exchange but these early improvements cannot be completely explained by modifications of respiratory compliance.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Age Factors
  • Combined Modality Therapy
  • Drug Combinations
  • Fatty Alcohols / therapeutic use*
  • Female
  • Humans
  • Hyaline Membrane Disease / drug therapy*
  • Hyaline Membrane Disease / physiopathology
  • Infant, Newborn
  • Infant, Premature, Diseases / drug therapy*
  • Infant, Premature, Diseases / physiopathology
  • Male
  • Phosphorylcholine*
  • Polyethylene Glycols / therapeutic use*
  • Prospective Studies
  • Pulmonary Surfactants / therapeutic use*
  • Respiration, Artificial
  • Respiratory Mechanics / drug effects*

Substances

  • Drug Combinations
  • Fatty Alcohols
  • Pulmonary Surfactants
  • Phosphorylcholine
  • Polyethylene Glycols
  • dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination